Higher body mass index at ages 16 to 20 years is associated with increased risk of a multiple sclerosis diagnosis in subsequent adulthood among men.


Journal

Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 9 6 2020
medline: 25 9 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

Evidence for the association between body mass index (BMI) and multiple sclerosis (MS) among men remains mixed. Swedish military conscription and other registers identified MS after age of 20 years and BMI at ages 16-20 years ( Each unit (kg/m MS risk rises with increasing BMI, across the entire BMI range.

Sections du résumé

BACKGROUND
Evidence for the association between body mass index (BMI) and multiple sclerosis (MS) among men remains mixed.
OBJECTIVE AND METHODS
Swedish military conscription and other registers identified MS after age of 20 years and BMI at ages 16-20 years (
RESULTS
Each unit (kg/m
CONCLUSION
MS risk rises with increasing BMI, across the entire BMI range.

Identifiants

pubmed: 32507076
doi: 10.1177/1352458520928061
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-150

Auteurs

Yin Xu (Y)

Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.

Ayako Hiyoshi (A)

Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.

Judith S Brand (JS)

Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.

Kelsi A Smith (KA)

Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden/Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Shahram Bahmanyar (S)

Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden/Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

Lars Alfredsson (L)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden/Centre for Occupational and Environmental Medicine, Stockholm, Sweden.

Tomas Olsson (T)

Department of Clinical Neuroscience, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Scott Montgomery (S)

Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden/Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden/Department of Epidemiology and Public Health, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH